Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPage revision tag updated from v3.2.0 to v3.3.2; no user-facing content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding/operating status notice was removed from the page; it was informational and not part of the study details.SummaryDifference0.3%

- Check42 days agoChange DetectedResults for the study NCT03547999 have been posted on ClinicalTrials.gov. The record now shows a Results First Posted date of 2025-07-22 along with the associated outcome measures.SummaryDifference0.4%

- Check71 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated to v3.0.2; the previous v3.0.1 revision tag and the 'Back to Top' element were removed.SummaryDifference0.1%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.